Evaro key facts
as of Oct 2026- Operator of an online health hub platform intended to offer patients paperless prescriptions and delivery.
- Evaro is valued at approximately $86.9M as of Oct 2026 (last reported valuation).
- It has raised $28.7M; the latest was Accelerator/Incubator in Mar 2026.
- Notable investors include Tech Nation Group, SyndicateRoom, British International Investment, AlbionVC, Life Extension Ventures — 15 tracked in total.
- Status: Privately Held (backing).
Evaro's last reported valuation, Jan 2026. Nothing priced has surfaced since.
- ·The complete investor list: 15 names
- ·Watch Evaro: the Monday email on marks, rounds and moves
Evaro funding rounds
No funding rounds for Evaro are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Evaro
15+Evaro valuation
Evaro's last reported valuation was $86.9 million in Jan 2026. No priced round, secondary trade or fund mark has surfaced since.
Evaro investors
15 investors are on record for Evaro, including Tech Nation Group, SyndicateRoom, British International Investment and AlbionVC. By type, the record holds 4 venture capital firms and 1 hedge fund.
About Evaro
Operator of an online health hub platform intended to offer patients paperless prescriptions and delivery. The company's platform helps its users choose medication by answering a questionnaire and delivering prescription treatment based on a prescribing system that reduces the need for excess paper waste, enabling healthcare professionals to help patients access healthcare online for confidential advice easily.
- Sector
- Healthcare
- HQ
- Norwich, United Kingdom
- Founded
- 2017
- Employees
- 79
- Website
- evaro.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.